Hari Shanker Bhartia Family Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Hari Shanker Bhartia Family Trust, part of the promoter group of Jubilant Pharmova, has submitted a disclosure to the exchange under Regulation 31(4) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. This is a compliance filing in which the promoter group declares details of their aggregate shareholding in the company and confirms that they will not acquire additional shares that would trigger the requirement to make an open offer. The headline does not disclose any specific change in shareholding, pledge activity, or change in promoter/FII stakes. This appears to be a routine annual or event-based regulatory submission by the promoter family trust.
No material impact on shareholders or stock price is expected from this filing, as it is a routine compliance disclosure by the promoter group without any stated change in ownership or encumbrance.